About
Benjamin Heng is a Research Fellow at the Macquarie Medical School, Macquarie University. His research focuses on metabolic pathways, particularly the kynurenine pathway, and their roles in cancer, neurodegenerative diseases, and chronic illnesses. He has led and contributed to several projects, including investigations into brain cancer immunosuppression, chronic fatigue syndrome mechanisms, and breast cancer metastasis. His work spans biomarker discovery, proteomic analyses, and translational research.
Key projects include:
- "Unravelling the ability of a metabolic pathway to suppress normal immune system function in brain cancer" (ongoing since 2016).
- "Biomarker and treatment discovery for myalgic encephalomyelitis/chronic fatigue-associated infectious diseases" (2024–2025).
- "The Susie Myers Scholarship for Glioblastoma Multiforme (GBM) research" (2022–2024).
His research interests include cancer biology, immunology, neurodegeneration, and metabolic disorders. He has published over 80 papers, with a focus on kynurenine pathway dysregulation in diseases like multiple sclerosis, Alzheimer’s, and breast cancer. His studies often integrate proteomics, metabolomics, and multi-omics approaches to identify novel therapeutic targets and biomarkers.
Heng has organized academic events, such as the 2017 EnCouRage Research Symposium. His work has been cited over 1,600 times, reflecting significant contributions to understanding disease mechanisms and developing diagnostic tools.
